ARCHIVES

Drugs and Targets: EU approves Imbruvica in MCL, CLL

This article is from The Cancer Letter archive.

Vol. 40 No. 40 | October 24, 2014

Download PDF Visit The Full Archive

Related Articles

Lifestyle Changes Common After Cancer Diagnosis

August 26, 2005

Arsenic Compound Improves Survival Of Adults With APL

February 23, 2007

In Brief: Lobuglio Named Alabama Comprehensive Center Director; NCI FY 1983 Funds Will Be $983.6 Million

January 7, 1983

Ovarian Cancer Screening Finds Cancers, But Also Many False Positives, Study Says

November 25, 2005

NCI Viewed As NIH’s ‘Administrative Reserve,” Broder Tells Directors

July 12, 1991

In Brief: NCAB Meeting Set For Oct. 3-5; Second Workshop On Tumor Cell Cloning Jan. 3-5

August 24, 1979